关注
Scott R. Walker
Scott R. Walker
未知所在单位机构
在 csiro.au 的电子邮件经过验证
标题
引用次数
引用次数
年份
Variolins and related alkaloids
SR Walker, EJ Carter, BC Huff, JC Morris
Chemical reviews 109 (7), 3080-3098, 2009
2902009
Potent Inhibitors of a Shikimate Pathway Enzyme from Mycobacterium tuberculosis combining mechanism-And modeling-based design
S Reichau, W Jiao, SR Walker, RD Hutton, EN Baker, EJ Parker
Journal of Biological Chemistry 286 (18), 16197-16207, 2011
612011
Characterization of the novel broad-spectrum kinase inhibitor CTx-0294885 as an affinity reagent for mass spectrometry-based kinome profiling
L Zhang, IP Holmes, F Hochgräfe, SR Walker, NA Ali, ES Humphrey, ...
Journal of proteome research 12 (7), 3104-3116, 2013
582013
Structural determinants for small-molecule activation of skeletal muscle AMPK α2β2γ1 by the glucose importagog SC4
KRW Ngoei, CG Langendorf, NXY Ling, A Hoque, S Varghese, ...
Cell chemical biology 25 (6), 728-737. e9, 2018
512018
Concise syntheses of meridianins and meriolins using a catalytic domino amino-palladation reaction
SR Walker, ML Czyz, JC Morris
Organic letters 16 (3), 708-711, 2014
442014
Synthesis and evaluation of a mechanism-based inhibitor of a 3-deoxy-D-arabino heptulosonate 7-phosphate synthase
SR Walker, EJ Parker
Bioorganic & medicinal chemistry letters 16 (11), 2951-2954, 2006
322006
Substrate and reaction intermediate mimics as inhibitors of 3-deoxy-D-arabino-heptulosonate 7-phosphate synthase
SR Walker, H Cumming, EJ Parker
Organic & Biomolecular Chemistry 7 (15), 3031-3035, 2009
252009
Discovery of a highly potent, selective, orally bioavailable inhibitor of KAT6A/B histone acetyltransferases with efficacy against KAT6A-high ER+ breast cancer
S Sharma, CY Chung, S Uryu, J Petrovic, J Cao, A Rickard, N Nady, ...
Cell Chemical Biology, 2023
222023
Synthesis and evaluation of dual site inhibitors of 3-deoxy-D-arabino-heptulosonate 7-phosphate synthase
SR Walker, W Jiao, EJ Parker
Bioorganic & medicinal chemistry letters 21 (17), 5092-5097, 2011
212011
Elimination of a hydroxyl group in FTY720 dramatically improves the phosphorylation rate
E Jary, T Bee, SR Walker, SK Chung, KC Seo, JC Morris, AS Don
Molecular pharmacology 78 (4), 685-692, 2010
202010
2-(hetero) aryl-benzimidazole and imidazopyridine derivatives as inhibitors of asparagime emethyl transferase
PA Stupple, SR Walker, JA Pinson, HR Lagiakos, GE Lunniss, IP Holmes, ...
US Patent 9,856,252, 2018
102018
Tetrahydroisoquinoline derived PRMT5-inhibitors
YE Bergman, RC Foitzik, BJ Morrow, MA Camerino, SR Walker, ...
US Patent 10,494,376, 2019
92019
Diagnostic fragmentations of adducts formed between carbanions and carbon disulfide in the gas phase. A joint experimental and theoretical study
MJ Maclean, S Walker, T Wang, PCH Eichinger, PJ Sherman, JH Bowie
Organic & biomolecular chemistry 8 (2), 371-377, 2010
82010
Tetrahydroisoquinoline derived PRMT5-inhibitors
RC Foitzik, MA Camerino, SR Walker, HR Lagiakos
US Patent 10,647,708, 2020
72020
Aminoindane-, aminotetrahydronaphthalene-and aminobenzocyclobutane-derived PRMT5-inhibitors
YE Bergman, R Lessene, D Ganame, RC Foitzik, BJ Morrow, ...
US Patent 10,005,792, 2018
72018
FAK inhibitors
IP Holmes, Y Bergman, GE Lunniss, M Nikac, N Choi, CF Hemley, ...
US Patent 9,012,461, 2015
62015
Tetrahydroisoquinolines as PRMT5 inhibitors
YE Bergman, MA Camerino, SR Walker, PA Stupple
US Patent 10,421,743, 2019
52019
PRMT5 inhibitors as novel treatment for cancers
H Falk, RC Foitzik, E Allan, M deSilva, H Yang, YE Bozikis, M Nikac, ...
Cancer Research 75 (15_Supplement), 5371-5371, 2015
42015
Inhibition of Focal Adhesion Kinase in Combination With Bevacizumab Reduces the Rate of Tumor Revascularization and Increases Survival in a Pre-clinical Model of Basal Breast …
I Street, I Holmes, M Devlin, Y Bergman, J Doherty, A Natoli, H Falk, ...
EUROPEAN JOURNAL OF CANCER 48, S203-S203, 2012
42012
Selective FAK inhibitors
IP Holmes, Y Bergman, GE Lunniss, M Nikac, N Choi, CF Hemley, ...
US Patent 9,174,946, 2015
32015
系统目前无法执行此操作,请稍后再试。
文章 1–20